Heart-stopping news. The diabetes drug Avandia is under fire: what you should know. Interview by Avery Comarow.
作者信息
Psaty Bruce
出版信息
US News World Rep. 2007 Jun 4;142(20):64.
PMID:17632813
Abstract
摘要
相似文献
1
Heart-stopping news. The diabetes drug Avandia is under fire: what you should know. Interview by Avery Comarow.
US News World Rep. 2007 Jun 4;142(20):64.
2
Avandia in perspective.
US News World Rep. 2007 Oct 1;143(11):71.
3
The Avandia debate.
Diabetes Care. 2007 Sep;30(9):2401-8. doi: 10.2337/dc07-zb09.
4
Diabetes drug safety update: Avandia and your heart.
Johns Hopkins Med Lett Health After 50. 2010 Jun;22(4):1-2, 7.
5
Drug safety. Heart attack risk overshadows a popular diabetes therapy.
Science. 2007 Jun 15;316(5831):1550-1. doi: 10.1126/science.316.5831.1550.
6
Outlook on diabetes drug less than rosy. Early work suggests that rosiglitazone (Avandia) may not be best for the heart.
Harv Heart Lett. 2007 Aug;17(12):1-2.
7
FDA panel advises easing restrictions on rosiglitazone.
BMJ. 2013 Jun 10;346:f3769. doi: 10.1136/bmj.f3769.
8
Avandia and your heart.
Diabetes Forecast. 2007 Jul;60(8):16.
9
Reviewer leaked Avandia study to drug firm.
Nature. 2008 Jan 31;451(7178):509. doi: 10.1038/451509a.
10
Rosiglitazone, medical reversal, and back to basics for diabetes.
Am Fam Physician. 2014 Sep 15;90(6):368, 370.
Zotero 插件